New York, NY 5/9/08—Enzo Biochem has acquired BIOMOL International for $15 million in cash, $3 million in unregistered stock, and earn outs over two year. BIOMOL is a provider of more than 3,300 products for the areas of signal transduction, lipid research, apoptosis, neuroscience and drug discovery with a research focus in functional proteomics. Based […]
The 2007 IBO Executive Compensation Survey includes 57 executives from 42 companies and is based upon the companies currently in IBO’s three Stock Indexes (see IBO 4/30/08) and Becton Dickinson. QIAGEN, Nanometrics and Starlims are excluded as a result of incomplete filings. To create the tables, IBO selected one or two executives for each company […]
Atomic force microscopy’s (AFM) advent at the start of the semiconductor boom provided the technology an introduction into the private sector, but AFM’s potential is still being discovered. Park Systems specializes in AFM systems for research and industrial applications. AFM both measures and provides an image of a sample’s surface with subnanometer resolution by running […]
Company Announcements In February, Covidien announced that it plans to divest its Specialty Chemical division, which includes the Mallinckrodt Baker laboratory chemicals business. In fiscal 2007, Specialty Chemicals revenue totaled $422 million. The company expects to complete the sale by year end. Ace Glass signed a multiyear agreement with VWR to become a core supplier […]
Company Announcements Crosslinks BV joined InforSense’s Open Partner Network. LabWare’s 2007 revenues increased over 14% to $70 million and the company signed over 75 new customers. CAMO Software AS opened an Australian office in Sydney in March. Symyx Technologies joined the Microsoft BioIT Alliance. Agilent will distribute an embedded version of Accelrys’ SciTegic Pipeline Pilot […]
Norwalk, CT 5/9/08—By July 1, Celera will separate from Applera by means of a redemption of all the outstanding shares of the Celera tracking stock (see IBO 2/29/08). Celera will list on the NASDAQ Stock Market.
Company Announcements In 2007, ThalesNano opened a UK subsidiary and signed distribution agreement for Scandinavia, Italy and India. ThalesNano announced a collaboration for flow/microwave chemistry research with the Christian Doppler Laboratory for Microwave Chemistry at Karl Franzens University in Austria and with the Swiss Federal Institute of Technology Zurich. PolyGen named Blue Lion Biotech its […]
Huntingdon, UK 4/23/08—NextGen Sciences has announced that it plans to divest or dissolve its software and instrumentation business and its protein production business within the next six months. The company intends to focus on its life science–research service business, particularly biomarker services. The company also plans to move its headquarters to the US.
Agriculture: Across the globe, governments and biotech companies are attempting to reconcile food shortages and increasing food prices with strict regulations on genetically modified (GM) crops. In a recent move, food manufacturers in Japan and Korea have abandoned their adherence to unmodified corn, which has increased three times in price from 2006, for its GM […]
Before the digital and automation age, cell counting was performed by using a microscope paired with a hemocytometer. While this decades-old manual method is still being utilized by labs, the primary advantage of this technique is its low cost. Its many drawbacks include a lack of precision, low accuracy, lot-to-lot variability and labor intensiveness. In […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
